Treatments of Renal Failure
Links shared publicly online about this topic
Most Recently Shared on September 11, 2012 at 9:00 pm By:
Affymax and Takeda Confirm U.S. Registration Strategy for Investigational Drug, Hematide/peginesatide, Following Meeting with FDA
drugs.com — “Hematide (peginesatide) is a new drug in development for the treatment of anemia in chronic renal failure. Hematide information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on December 1, 2010 at 11:06 pm By:
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic